Sponsor pipeline

Beijing Northland Biotech. Co., Ltd. clinical trial pipeline

Get alerts when Beijing Northland Biotech. Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07586865 Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction Acute Myocardial Infarction (AMI) Not Yet Recruiting 2026-05-14
Not specified
NCT07023965 Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) Peripheral Arterial Disease(PAD) Enrolling by Invitation 2025-07-11

Disease areas by active trials

Diabetes (1) · Heart Disease (1)

Get alerts when Beijing Northland Biotech. Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free